Correlation Between Salarius Pharmaceuticals and Forte Biosciences
Can any of the company-specific risk be diversified away by investing in both Salarius Pharmaceuticals and Forte Biosciences at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Salarius Pharmaceuticals and Forte Biosciences into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Salarius Pharmaceuticals and Forte Biosciences, you can compare the effects of market volatilities on Salarius Pharmaceuticals and Forte Biosciences and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Salarius Pharmaceuticals with a short position of Forte Biosciences. Check out your portfolio center. Please also check ongoing floating volatility patterns of Salarius Pharmaceuticals and Forte Biosciences.
Diversification Opportunities for Salarius Pharmaceuticals and Forte Biosciences
-0.18 | Correlation Coefficient |
Good diversification
The 3 months correlation between Salarius and Forte is -0.18. Overlapping area represents the amount of risk that can be diversified away by holding Salarius Pharmaceuticals and Forte Biosciences in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Forte Biosciences and Salarius Pharmaceuticals is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Salarius Pharmaceuticals are associated (or correlated) with Forte Biosciences. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Forte Biosciences has no effect on the direction of Salarius Pharmaceuticals i.e., Salarius Pharmaceuticals and Forte Biosciences go up and down completely randomly.
Pair Corralation between Salarius Pharmaceuticals and Forte Biosciences
Given the investment horizon of 90 days Salarius Pharmaceuticals is expected to under-perform the Forte Biosciences. In addition to that, Salarius Pharmaceuticals is 1.01 times more volatile than Forte Biosciences. It trades about -0.04 of its total potential returns per unit of risk. Forte Biosciences is currently generating about 0.02 per unit of volatility. If you would invest 2,488 in Forte Biosciences on August 31, 2024 and sell it today you would lose (317.00) from holding Forte Biosciences or give up 12.74% of portfolio value over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Against |
| Strength | Insignificant |
| Accuracy | 100.0% |
| Values | Daily Returns |
Salarius Pharmaceuticals vs. Forte Biosciences
Performance |
| Timeline |
| Salarius Pharmaceuticals |
| Forte Biosciences |
Salarius Pharmaceuticals and Forte Biosciences Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Salarius Pharmaceuticals and Forte Biosciences
The main advantage of trading using opposite Salarius Pharmaceuticals and Forte Biosciences positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Salarius Pharmaceuticals position performs unexpectedly, Forte Biosciences can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Forte Biosciences will offset losses from the drop in Forte Biosciences' long position.| Salarius Pharmaceuticals vs. Akari Therapeutics PLC | Salarius Pharmaceuticals vs. Histogen | Salarius Pharmaceuticals vs. Nutriband | Salarius Pharmaceuticals vs. Aileron Therapeutics |
| Forte Biosciences vs. Indaptus Therapeutics | Forte Biosciences vs. Rezolute | Forte Biosciences vs. Tempest Therapeutics | Forte Biosciences vs. ABVC Biopharma |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Manager module to state of the art Portfolio Manager to monitor and improve performance of your invested capital.
Other Complementary Tools
| Sign In To Macroaxis Sign in to explore Macroaxis' wealth optimization platform and fintech modules | |
| Fundamentals Comparison Compare fundamentals across multiple equities to find investing opportunities | |
| Portfolio Manager State of the art Portfolio Manager to monitor and improve performance of your invested capital | |
| My Watchlist Analysis Analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like | |
| Positions Ratings Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance |